Earnings Feed
Start Free
BIOCANCELL THERAPEUTICS INC.·5

Feb 28, 2:11 PM ET

NEVO DORON 5

5 · BIOCANCELL THERAPEUTICS INC. · Filed Feb 28, 2011

Insider Transaction Report

Form 5
Period: 2010-12-31
BIOCANCELL THERAPEUTICS INC.BICL.TA
NEVO DORON
Director
Transactions
  • Purchase

    Series 3 Warrants

    2010-11-23+100,000→ 100,000 total
    Exp: 2012-11-17→ Common Stock (100,000 underlying)
  • Purchase

    Series 4 Warrants

    2010-12-01+50,000→ 99,995 total
    Exp: 2014-11-17→ Common Stock (50,000 underlying)
  • Purchase

    Series 4 Warrants

    2010-12-02+49,995→ 99,995 total
    Exp: 2014-11-17→ Common Stock (49,995 underlying)
Footnotes (6)
  • [F1]The exercise price of Series 3 Warrants is 3.69 NIS per share.
  • [F2]The warrants are exercisable at any time until their expiration.
  • [F3]The average purchase price was 0.57 NIS per warrant.
  • [F4]The exercise price of Series 4 Warrants is 4.43 NIS per share.
  • [F5]The average purchase price was 0.60 NIS per warrant.
  • [F6]The average purchase price was 0.57 NIS per warrant.

Documents

1 file
  • 5
    doc1.xmlPrimary

    FORM 5